Sign up for free insights newsletter
DG

DIAGNOS Inc

DGNOFUnited States

Need professional-grade analysis? Visit stockanalysis.com

$0.20
+3.11%
End of day
Market Cap

$25.05M

P/E Ratio

N/A

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-1.370.24-0.10-0.30
Calmar-2.290.39-0.14-0.50
Sharpe-1.010.16-0.07-0.23
Omega0.741.101.060.99
Martin-3.960.73-0.30-0.87
Ulcer16.8615.6316.6816.37

DIAGNOS Inc (DGNOF) Price Performance

DIAGNOS Inc (DGNOF) trades on United States in USD. The company is classified in the Healthcare sector under the Health Information Services industry. The stock currently trades at $0.20, up 3.11% from the previous close.

Over the past year, DGNOF has traded between a low of $0.13 and a high of $0.27. The stock has lost 2.1% over this period. It is currently 27.4% below its 52-week high.

DIAGNOS Inc has a market capitalization of $25.05M.

About DIAGNOS Inc

DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, Chile, and internationally. It offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy, as well as allows eye care specialist to visualize normal retinal landmarks and pathological changes. The company also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.

Company Info

Exchange
United States
Currency
USD

Financial Metrics

Revenue (TTM)
$68,159
EBITDA
$-4,488,244
Profit Margin
-4129.65%
EPS (TTM)
-0.04
Book Value
0.01

Technical Indicators

52 Week High
$0.29
52 Week Low
$0.13
50 Day MA
$0.22
200 Day MA
$0.20
Beta
-0.17

Valuation

Trailing P/E
N/A
Forward P/E
10.36
Price/Sales
367.49
Price/Book
23.20
Enterprise Value
$24.70M